Viewing Study NCT04728932


Ignite Creation Date: 2025-12-24 @ 9:27 PM
Ignite Modification Date: 2026-05-26 @ 10:19 PM
Study NCT ID: NCT04728932
Status: COMPLETED
Last Update Posted: 2025-03-21
First Post: 2021-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cardiogenic Shock View
None Extracorporeal Membrane Oxygenation Complication View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LEVOSIMENDAN View